These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34255491)

  • 1. Probing the Hidden Role of Mitochondrial DNA Damage and Dysfunction in the Etiology of Aristolochic Acid Nephropathy.
    Chan W; Ham YH
    Chem Res Toxicol; 2021 Aug; 34(8):1903-1909. PubMed ID: 34255491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.
    Arlt VM; Stiborova M; Schmeiser HH
    Mutagenesis; 2002 Jul; 17(4):265-77. PubMed ID: 12110620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.
    Schmeiser HH; Nortier JL; Singh R; Gamboa da Costa G; Sennesael J; Cassuto-Viguier E; Ambrosetti D; Rorive S; Pozdzik A; Phillips DH; Stiborova M; Arlt VM
    Int J Cancer; 2014 Jul; 135(2):502-7. PubMed ID: 24921086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics analysis of altered proteins in kidney of mice with aristolochic acid nephropathy using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method.
    Lin CE; Chang WS; Lee JA; Chang TY; Huang YS; Hirasaki Y; Chen HS; Imai K; Chen SM
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29088495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aristolochic acid causes albuminuria by promoting mitochondrial DNA damage and dysfunction in podocyte.
    Zhou Y; Bian X; Fang L; He W; Dai C; Yang J
    PLoS One; 2013; 8(12):e83408. PubMed ID: 24349506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive measurement of aristolochic acid-DNA adducts in urine samples from aristolochic acid-treated rats by liquid chromatography coupled tandem mass spectrometry: evidence for DNA repair by nucleotide-excision repair mechanisms.
    Leung EM; Chan W
    Mutat Res; 2014; 766-767():1-6. PubMed ID: 25847264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity?
    Pozdzik AA; Berton A; Schmeiser HH; Missoum W; Decaestecker C; Salmon IJ; Vanherweghem JL; Nortier JL
    Histopathology; 2010 Mar; 56(4):449-63. PubMed ID: 20459552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
    Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
    Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioaccumulation and DNA Adduct Formation of Aristolactam I: Unmasking a Toxicological Mechanism in the Pathophysiology of Aristolochic Acid Nephropathy.
    Au CK; Ham YH; Chan W
    Chem Res Toxicol; 2023 Feb; 36(2):322-329. PubMed ID: 36757010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aristolochic acid nephropathy ("Chinese herb nephropathy")].
    Nortier J; Pozdzik A; Roumeguere T; Vanherweghem JL
    Nephrol Ther; 2015 Dec; 11(7):574-88. PubMed ID: 26515658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.
    Jadot I; Declèves AE; Nortier J; Caron N
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aristolochic acid nephropathy and the peritoneum: Functional, structural, and molecular studies.
    Gillerot G; Goffin E; Moulin P; Arlt VM; Phillips DH; Cosyns JP; Devuyst O
    Kidney Int; 2003 Nov; 64(5):1883-92. PubMed ID: 14531824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice.
    Urate S; Wakui H; Azushima K; Yamaji T; Suzuki T; Abe E; Tanaka S; Taguchi S; Tsukamoto S; Kinguchi S; Uneda K; Kanaoka T; Atobe Y; Funakoshi K; Yamashita A; Tamura K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.
    Cosyns JP
    Drug Saf; 2003; 26(1):33-48. PubMed ID: 12495362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
    Stiborova M; Frei E; Arlt VM; Schmeiser HH
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aristolochic acid I metabolism in the isolated perfused rat kidney.
    Priestap HA; Torres MC; Rieger RA; Dickman KG; Freshwater T; Taft DR; Barbieri MA; Iden CR
    Chem Res Toxicol; 2012 Jan; 25(1):130-9. PubMed ID: 22118289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of
    Zhao Y; Chan CK; Chan KKJ; Chan W
    Chem Res Toxicol; 2019 Oct; 32(10):2086-2094. PubMed ID: 31476867
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective role of relaxin in a mouse model of aristolochic acid nephropathy.
    Yang X; Thorngren D; Chen Q; Wang M; Xie X
    Biomed Pharmacother; 2019 Jul; 115():108917. PubMed ID: 31060002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aristolochic acid nephropathy: A scientometric analysis of literature published from 1971 to 2019.
    Ji H; Hu J; Zhang G; Song J; Zhou X; Guo D
    Medicine (Baltimore); 2021 Jul; 100(27):e26510. PubMed ID: 34232183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aristolochic acid nephropathy: a worldwide problem.
    Debelle FD; Vanherweghem JL; Nortier JL
    Kidney Int; 2008 Jul; 74(2):158-69. PubMed ID: 18418355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.